Preferred Label : paliperidone;
CISMeF synonym : 9-hydroxy-risperidone;
UMLS semantic type : T109 - Organic Chemical; T121 - Pharmacologic Substance;
CAS number : 838F01T721;
Is substance : O;
UNII : 838F01T721;
InChIKey : PMXMIIMHBWHSKN-UHFFFAOYSA-N;
Origin ID : M0211957;
UMLS CUI : C0753678;
Currated CISMeF NLP mapping
MeSH narrower concept(s)
Related record
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://pharmacomedicale.org/component/zoo/item/risperidone-paliperidone
2022
France
drug information
Paliperidone Palmitate
paliperidone
risperidone
---
https://www.ema.europa.eu/en/medicines/human/EPAR/paliperidone-janssen-cilag-international
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
paliperidone
paliperidone
paliperidone
drug approval
europe
antipsychotic agents
antipsychotic agents
schizophrenia
adult
Delayed-Action preparations
injections, intramuscular
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Paliperidone Palmitate
Paliperidone Palmitate
---
https://www.ema.europa.eu/medicines/human/EPAR/trevicta-previously-paliperidone-janssen
2015
false
United Kingdom
English
French
drug evaluation
europe
syndication feed
paliperidone
paliperidone
Delayed-Action preparations
injections, intramuscular
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
drug approval
treatment outcome
antipsychotic agents
antipsychotic agents
paliperidone
adult
schizophrenia
summary of product characteristics
package leaflet
Paliperidone Palmitate
Paliperidone Palmitate
---
https://www.ema.europa.eu/medicines/human/EPAR/Invega
2012
false
United Kingdom
French
English
syndication feed
Paliperidone Palmitate
paliperidone
antipsychotic agents
schizophrenia
treatment outcome
drug evaluation
paliperidone
drug evaluation
summary of product characteristics
package leaflet
isoxazoles
pyrimidines
---
https://cadth.ca/sites/default/files/cdr/complete/cdr_complete_Invega%20_May-28-2008_f.pdf
2008
false
Canada
French
paliperidone
antipsychotic agents
schizophrenia
administration, oral
Delayed-Action preparations
insurance, health, reimbursement
canada
tablets
drug costs
paliperidone
drug evaluation
Paliperidone Palmitate
isoxazoles
pyrimidines
---
INVEGA Paliperidone, 3 mg, 6 mg, 9 mg, 12 mg, extended-release tablets Janssen-Ortho
Inc - Summary Basis of Decision (SBD)
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00075
2008
false
Canada
English
French
paliperidone
paliperidone
tablets
antipsychotic agents
drug approval
receptor, serotonin, 5-ht2a
dopamine antagonists
receptors, dopamine d2
treatment outcome
schizophrenia
administration, oral
antipsychotic agents
paliperidone
serotonin 5-HT2 receptor antagonists
drug information
package leaflet
Paliperidone Palmitate
Paliperidone Palmitate
isoxazoles
pyrimidines
isoxazoles
pyrimidines
---
http://www.has-sante.fr/portail/display.jsp?id=c_627649
2007
false
France
French
paliperidone
antipsychotic agents
schizophrenia
tablets
Delayed-Action preparations
administration, oral
treatment outcome
insurance, health, reimbursement
paliperidone
evaluation of the transparency committee
Paliperidone Palmitate
isoxazoles
pyrimidines
---